GR3034177T3 - Immunoglobulin g concentrate for therapeutical use and method for producing same - Google Patents

Immunoglobulin g concentrate for therapeutical use and method for producing same

Info

Publication number
GR3034177T3
GR3034177T3 GR20000401872T GR20000401872T GR3034177T3 GR 3034177 T3 GR3034177 T3 GR 3034177T3 GR 20000401872 T GR20000401872 T GR 20000401872T GR 20000401872 T GR20000401872 T GR 20000401872T GR 3034177 T3 GR3034177 T3 GR 3034177T3
Authority
GR
Greece
Prior art keywords
concentrate
pct
immunoglobulin
producing same
sec
Prior art date
Application number
GR20000401872T
Other languages
English (en)
Inventor
Miryana Burnouf
Dominique Dernis
Patrick Bonneel
Thierry Burnouf
Original Assignee
Aetsrn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aetsrn filed Critical Aetsrn
Publication of GR3034177T3 publication Critical patent/GR3034177T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
GR20000401872T 1993-06-14 2000-08-10 Immunoglobulin g concentrate for therapeutical use and method for producing same GR3034177T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9307128A FR2706466B1 (fr) 1993-06-14 1993-06-14 Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
PCT/FR1994/000699 WO1994029334A1 (fr) 1993-06-14 1994-06-13 Concentre d'immunoglobulines g a usage therapeutique et procede de production dudit concentre

Publications (1)

Publication Number Publication Date
GR3034177T3 true GR3034177T3 (en) 2000-11-30

Family

ID=9448094

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401872T GR3034177T3 (en) 1993-06-14 2000-08-10 Immunoglobulin g concentrate for therapeutical use and method for producing same

Country Status (16)

Country Link
US (1) US6069236A (el)
EP (1) EP0703922B1 (el)
JP (1) JP4218980B2 (el)
AT (1) ATE193020T1 (el)
AU (1) AU7002394A (el)
BR (1) BR9406814A (el)
CA (1) CA2165203C (el)
CZ (1) CZ287186B6 (el)
DE (1) DE69424545T2 (el)
DK (1) DK0703922T3 (el)
ES (1) ES2148332T3 (el)
FR (1) FR2706466B1 (el)
GR (1) GR3034177T3 (el)
HU (1) HU218463B (el)
PT (1) PT703922E (el)
WO (1) WO1994029334A1 (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281336B1 (en) * 1998-06-09 2001-08-28 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
RU2197500C2 (ru) * 1998-06-09 2003-01-27 Статенс Серум Институт Способ получения иммуноглобулинов для внутривенного введения и другие иммуноглобулиновые продукты
US6962700B1 (en) 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
FR2824568B1 (fr) * 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
WO2005046587A2 (en) 2003-11-08 2005-05-26 Prothera Biologics Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
EP1532983A1 (en) * 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
WO2007136327A1 (en) * 2006-05-22 2007-11-29 Ge Healthcare Bio-Sciences Ab A method of producing igg
TWI532498B (zh) 2008-03-17 2016-05-11 巴克斯特保健公司 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
CA2726281C (en) 2008-05-28 2023-04-18 Prothera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from blood
FR2939667B1 (fr) 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
MX2011012576A (es) 2009-05-27 2012-05-08 Baxter Int Metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo.
WO2010148117A1 (en) 2009-06-17 2010-12-23 Scantibodies Laboratory, Inc. Therapeutic and diagnostic affinity purified specific polyclonal antibodies
KR101441768B1 (ko) 2009-09-17 2014-09-17 박스터 헬쓰케어 에스에이 히알루로니다아제 및 면역글로불린의 안정한 복합제제, 및 그 사용방법
IT1397061B1 (it) 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
AU2011212440B2 (en) 2010-02-04 2015-01-22 Csl Behring Ag Immunoglobulin preparation
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
EP2640413B1 (en) 2010-11-16 2019-06-12 Octapharma AG A process for reduction and/or removal of fxi and fxia from solutions containing said coagulation factors
JP6189751B2 (ja) 2010-12-30 2017-08-30 ラボラトワール フランセ デュ フラクショヌマン エ デ ビオテクノロジーLaboratoire Francais du Fractionnement et des Biotechnologies 病原体不活性化剤としてのグリコール
FR2974301B1 (fr) 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
EP2522354B1 (en) 2011-05-12 2017-08-23 CSL Behring GmbH Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
FR2977893B1 (fr) 2011-07-11 2015-02-20 Lab Francais Du Fractionnement Procede de preparation d'un concentre d'immunoglobulines polyvalentes
CN103874708B (zh) 2011-08-26 2018-07-10 百深有限责任公司 用于降低血浆来源免疫球蛋白组合物的血栓栓塞可能性的方法
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之i-iv-1部分沉澱
EP3590960B1 (en) 2012-02-29 2023-03-29 Takeda Pharmaceutical Company Limited Igg stimulated remyelination of peripheral nerves
SG11201404958SA (en) 2012-03-09 2014-11-27 Csl Behring Ag Compositions comprising secretory - like immunoglobulins
EP2636681A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Process for enriching IgA
EP2636684A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Prevention of infection
AU2013312215C1 (en) 2012-09-09 2018-09-06 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
US20140206844A1 (en) * 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
PL3016729T3 (pl) * 2013-07-05 2020-09-07 Laboratoire Français Du Fractionnement Et Des Biotechnologies Société Anonyme Matryca do chromatografii powinowactwa
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
US10287315B2 (en) * 2014-03-11 2019-05-14 Green Cross Holdings Corporation Method for purifying immunoglobulin
FR3018450B1 (fr) 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
US9556253B2 (en) * 2014-12-02 2017-01-31 Hemarus Therapeutics Limited Process for increased yield of immunoglobulin from human plasma
FR3064485A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Traitement d'une infection par le virus respiratoire syncytial
FR3064484A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Composition d'immunoglobulines utiles pour traiter des infections virales
FR3064486A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Prevention d'une infection par le virus respiratoire syncytial dans les voies respiratoires superieures
KR20220161332A (ko) 2020-03-31 2022-12-06 다케다 야쿠힌 고교 가부시키가이샤 C-1 억제제 고갈 혈장으로부터 면역글로불린 조제물을 제조하는 방법
KR20230125282A (ko) 2020-12-28 2023-08-29 플라즈마 테크놀로지스, 엘엘씨 면역글로불린 G의 공정 규모 단리를 위한 시스템 및방법 (Systems and Methods for Process Scale Isolation of Immunoglobulin G)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7511055A (nl) * 1975-09-19 1977-03-22 Leuven Res & Dev Vzw Trombosetest.
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
ES8203612A1 (es) * 1981-06-04 1982-04-01 Landerlan Sa Lab Procedimiento de preparacion de imuno globulina g nativa li-bre de actividad anticomplementaria
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4841024A (en) * 1986-09-15 1989-06-20 Becton Dickinson And Company Purification of antibodies
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US4806346A (en) * 1986-12-16 1989-02-21 American Home Products Corporation Method for isolation of antigen specific immunoglobulin
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
DE4118912C1 (el) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De

Also Published As

Publication number Publication date
BR9406814A (pt) 2000-05-30
WO1994029334A1 (fr) 1994-12-22
HU9503557D0 (en) 1996-02-28
CZ287186B6 (en) 2000-10-11
JP4218980B2 (ja) 2009-02-04
ATE193020T1 (de) 2000-06-15
AU7002394A (en) 1995-01-03
DE69424545D1 (de) 2000-06-21
HUT74272A (en) 1996-11-28
DK0703922T3 (da) 2000-11-13
EP0703922A1 (fr) 1996-04-03
CA2165203C (fr) 2009-08-18
FR2706466A1 (fr) 1994-12-23
CZ328795A3 (en) 1996-07-17
HU218463B (hu) 2000-09-28
US6069236A (en) 2000-05-30
EP0703922B1 (fr) 2000-05-17
FR2706466B1 (fr) 1995-08-25
CA2165203A1 (fr) 1994-12-22
ES2148332T3 (es) 2000-10-16
PT703922E (pt) 2000-11-30
JPH09500369A (ja) 1997-01-14
DE69424545T2 (de) 2001-01-18

Similar Documents

Publication Publication Date Title
GR3034177T3 (en) Immunoglobulin g concentrate for therapeutical use and method for producing same
AU5152293A (en) Treatment of autoimmune and inflammatory disorders
HU9402392D0 (en) Use of substituted adenine derivatives for treating multiple sclerosis
GEP20001940B (en) Valaciclovir Hydrochloride in Essentially Anhydrous Crystalline Form, Processes for its Producing, Use and Method of Treatment
AU7935487A (en) Immunotoxin therapy of allergy
CY2583B2 (en) Reshaped monoclonal antibodies against an immunoglobulin isotype
ATE213252T1 (de) Verfahren zur herstellung eines inter-alpha- trypsin inhibitor konzentrats mit therapeutischer anwendung und so erhaltenes konzentrat
ES2168294T3 (es) Derivados de tiazol o imidazol inhibidores de la reaccion de maillard.
HUT47307A (en) Process for producing 17beta-(cyclopropylamino)-androst-5-en-3beta-ol and its derivatives
AU3687593A (en) A method of producing a factor VIII preparation
EP0493446A4 (en) Treatment of autoimmune disease
MY117328A (en) Production process for intravenous immune serum globulin and resultant product.
AU4876196A (en) A process for the preparation of factor ix from biological sources
ATE239470T1 (de) Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
ATE320263T1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
AU5417696A (en) Substituted tetronic acids useful for treating hiv and other retroviruses
AU7230894A (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
UA10038A (uk) Спосіб лікування спондилоартрозу дуговідросчатих суглобів хребта
DE69625819D1 (de) Die verwendung von ondansetron zur herstellung eines medikamentes zur behandlung von tremor
ES2094701A1 (es) Procedimiento para la produccion de antitrombina iii